Abstract:Excessive tau protein phosphorylation is important in the pathogenesis and early abnormal signal transduction of Alzheimer's disease. Excessive phosphorylation of microtubules is associated with tau accumulation, which induces the formation of neurofibrillary tangles in neurons, leading to synaptic damage and ultimately, neurodegeneration. The present study aimed to investigate the possible mechanism underlying the inhibitory effects of puerarin on β-amyloid peptide (Aβ)1-42-induced tau protein hyperphosphorylation in SH-SY5Y cells. Following various treatments, the viability of SH-SY5Y cells was determined using the MTT assay, and cell morphology was observed under an inverted fluorescence microscope. Western blotting was used to detect tau phosphorylation, and the protein expression levels of glycogen synthase kinase (GSK)-3β, phosphorylated (p)-GSK-3β (Ser9), β-catenin and cyclin D1, which are the key factors mediating the Wnt/β-catenin signaling pathway in SH-SY5Y cells. The results demonstrated that puerarin reversed the Aβ1-42-induced decrease in SH-SY5Y cell viability. In addition, puerarin inhibited the degree of Aβ1-42-induced tau phosphorylation at Ser396, Ser199 and Thr231 in SH-SY5Y cells, and reduced the expression of GSK-3β by increasing the expression of p-GSK-3β (Ser9). Furthermore, puerarin increased the protein expression levels of β-catenin and cyclin D1, which are key factors involved in the Wnt/β-catenin signaling pathway. The results of the present study demonstrated that puerarin may attenuate Aβ1-42-induced tau hyperphosphorylation in SH-SY5Y cells, by inhibiting the expression of GSK-3β and activating the Wnt/β-catenin signaling pathway; therefore, puerarin may exert protective effects against Alzheimer's disease. Introduction Alzheimer's disease (AD), also known as senile dementia, is a degenerative disease of the central nervous system that is predominantly characterized by progressive degeneration of cognitive function and memory loss. Previous studies have suggested that disorders of the Wnt/β-catenin signaling pathway in the brains of patients with AD may be associated with pathological alterations (1,2), including formation of neurofibrillary tangles (NFTs) involving neurites and phosphorylated tau proteins, and neuronal loss and senile plaques triggered by β-amyloid peptide (Aβ) accumulation. The Wnt/β-catenin signaling pathway may therefore be considered the core pathway linking Aβ neurotoxicity with tau hyperphosphorylation. Glycogen synthase kinase (GSK)-3β is a multifunctional serine/threonine kinase and a negative regulator of Wnt/β-catenin signaling. Its abnormal expression is closely associated with the pathogenesis, pathological manifestations and treatment of AD (2). Previous studies have suggested that GSK-3β is a protein kinase that may induce abnormal tau phosphorylation in the brains of patients with AD and phosphorylation of tau at numerous sites (3,4). Puerarin is the main active ingredient derived from the Chinese herb root of Pueraria lobata, which is a selective inhibitor of GSK-3β (5,6). Previous research has indicated that puerarin downregulates Aβ expression in the brain, inhibits the abnormal expression of tau protein induced by Aβ, reduces cellular apoptosis, and improves learning and memory in animals (7-10). Puerarin exhibits anti-AD activity by inhibiting the activity of GSK-3β and activating the Wnt/β-catenin signaling pathway. At present, it is unknown whether puerarin ameliorates AD via the Wnt/β-catenin signaling pathway. Therefore, the present study aimed to investigate the role of oligomeric peptide Aβ1-42 in SH-SY5Y cell impairment, and the inhibitory effects of puerarin on tau hyperphosphorylation via the Wnt/β-catenin pathway. Materials and methods Drugs and reagents. The SH-SY5Y human neuroblastoma cell line was obtained from the Chinese Academy of Sciences, Kunming Cell Biological Research Institute (Kunming, Puerarin inhibits β‐amyloid peptide 1‐42‐induced tau hyperphosphorylation via the Wnt/β‐catenin signaling pathway YING YAO1, XIANCHUN CHEN2, YUTING BAO3 and YANGSHENG WU3 1Department of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang 310053; 2Department of Pharmacy, Zhejiang University Hospital, Hangzhou, Zhejiang 310012; 3Department of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China Received September 29, 2016; Accepted July 18, 2017 DOI: 10.3892/mmr.2017.7702 Correspondence to: Dr Ying Yao, Department of Pharmacy, Hangzhou Medical College, 481 Binwen Road, Hangzhou, Zhejiang 310053, P.R. China E-mail: realghost1978@163.com

P1‐295: Mimic Phosphorylation of SET at Ser 9 Promotes an Inhibition of PP2A

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

14-3-3Ζ Captures SET in the Cytoplasm, Mediating Tau Pathology and Cognitive Impairments

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

PP2A Subunit PPP2R2C is Downregulated in the Brains of Alzheimer's Transgenic Mice.

Cyclin-dependent Kinase 1-Mediated Phosphorylation of SET at Serine 7 is Essential for Its Oncogenic Activity

Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation

Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein

Abnormal Phosphorylation at Ser293 promotes the Oligomerization of Tau Repeat R2: A Computational Study

Tumor Suppressor PTEN Affects Tau Phosphorylation: Deficiency in the Phosphatase Activity of PTEN Increases Aggregation of an FTDP-17 Mutant Tau

Abstract. Excessive tau protein phosphorylation is important in the pathogenesis and early abnormal signal transduction of Alzheimer's disease. Excessive phosphorylation of micro- tubules is associated with tau accumulation, which induces the formation of neurofibrillary tangles in neurons, leading

Pseudo-phosphorylation at AT8 Epitopes Regulates the Tau Truncation at Aspartate 421

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Setdb1-mediated Histone H3K9 Hypermethylation in Neurons Worsens the Neurological Phenotype of Mecp2-deficient Mice

O2-01-05

Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP

Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization

Site‐specific phosphorylation of tau impacts mitochondrial function and response to stressors

Phosphorylation at serine 214 correlates with tau seeding activity in an age-dependent manner in two mouse models for tauopathies and is required for tau transsynaptic propagation.

Serine 129 Phosphorylation Reduces The Ability Of Alpha-Synuclein To Regulate Tyrosine Hydroxylase And Protein Phosphatase 2a In Vitro And In Vivo